United Laboratories International (ULIHF) Projected to Post Quarterly Earnings on Tuesday

United Laboratories International (OTCMKTS:ULIHF) will likely be posting its results before the market opens on Tuesday, March 24th. Analysts expect United Laboratories International to post earnings of $0.0315 per share and revenue of $783.4010 million for the quarter.

United Laboratories International Price Performance

ULIHF stock opened at $1.70 on Tuesday. United Laboratories International has a 52-week low of $1.60 and a 52-week high of $1.70. The company’s 50-day simple moving average is $1.80 and its 200-day simple moving average is $1.90.

United Laboratories International Company Profile

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.